ArticleJournal of cancer research and clinical oncology2016

Riproximin modulates multiple signaling cascades leading to cytostatic and apoptotic effects in human breast cancer cells.

Asim Pervaiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.